WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics

Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to many innovative diagnostic radiopharmaceuticals that can diagnose and monitor conditions such as Parkinson’s disease, advanced cardiac disease, cancers of the prostate, breast, and brain. The technology has also been integral to validating an Alzheimer’s diagnosis for many patients, like Geri Taylor, by confirming the presence of amyloid plaques in the brain.

Watch as Geri’s husband, Jim, talks about why Congressional action is needed to improve access to these critical drugs:

Please join Jim, Geri and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose Alzheimer’s disease and many others.

Click here to send you letter today.

More Articles

Congressional Briefing Discusses the Potential of Focused Ultrasound Therapy

May 6, 2024

With high incidences of neurologic conditions like chronic pain, childhood brain tumors, and mental illnesses, the need is…

Read More

Advocating for Equitable Access to AI in Healthcare During National Minority Health Month

April 24, 2024

Each April, National Minority Health Month reminds us of the importance of supporting policies that address healthcare disparities…

Read More

Colorectal Cancer Awareness Month: Your Guide to Prevention and Early Detection

March 19, 2024

March is Colorectal Cancer Awareness Month, a time dedicated to increasing awareness and encouraging prevention of one of…

Read More

How AI is Shaping Patient-Centric Healthcare

February 26, 2024

You may have seen artificial intelligence (AI) dominating the headlines recently – and for good reason. AI has…

Read More